Home/Filings/4/0001415889-25-011996
4//SEC Filing

Borgman Anne Elizabeth 4

Accession 0001415889-25-011996

CIK 0001382101other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 5:45 PM ET

Size

13.4 KB

Accession

0001415889-25-011996

Insider Transaction Report

Form 4
Period: 2025-05-01
Borgman Anne Elizabeth
CHIEF MEDICAL OFFICER
Transactions
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2025-05-0115,93817,812 total
    Exp: 2028-03-01Common Stock (15,938 underlying)
  • Exercise/Conversion

    Common Stock

    2025-05-01+53,125106,223 total
  • Exercise/Conversion

    Common Stock

    2025-05-01+15,938122,161 total
  • Tax Payment

    Common Stock

    2025-05-01$1.07/sh24,709$26,43997,452 total
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2025-05-0153,12521,875 total
    Exp: 2027-02-28Common Stock (53,125 underlying)
Footnotes (5)
  • [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
  • [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
  • [F3]The RSU award vests as to 1/4th of the total award annually on the last calendar day of February, beginning on February 29, 2024, subject to continued service through each vesting date.
  • [F4]The reported transactions represent the accelerated vesting of certain of the reporting person's equity awards outstanding under the issuer's 2018 Equity Incentive Plan and 2021 Equity Inducement Plan, in connection with her separation and transition from her position with the issuer, as previously reported by the issuer in its Current Report filed with the Securities and Exchange Commission on Form 8-K on March 13, 2025.
  • [F5]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.

Issuer

SUTRO BIOPHARMA, INC.

CIK 0001382101

Entity typeother

Related Parties

1
  • filerCIK 0001886388

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:45 PM ET
Size
13.4 KB